<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="disease time-course and reduce the severity of symptoms. Adamantane derivatives," exact="amantadine" post="(Symmetrel) and rimantadine (Flumadine), are small molecule inhibitors that"/>
 <result pre="reduce the severity of symptoms. Adamantane derivatives, amantadine (Symmetrel) and" exact="rimantadine" post="(Flumadine), are small molecule inhibitors that target M2 proteins"/>
 <result pre="influenza A viruses. [111]. Orally delivered oseltamivir (Tamiï¬‚u), intranasally administered" exact="zanamivir" post="(Relenza), and intravenously injected peramivir (Rapivab) are FDA approved"/>
 <result pre="delivered oseltamivir (Tamiï¬‚u), intranasally administered zanamivir (Relenza), and intravenously injected" exact="peramivir" post="(Rapivab) are FDA approved NA inhibitors that prevent the"/>
 <result pre="virus release from infected host cells. In 2018, FDA approved" exact="Baloxavir marboxil" post="(Xofluza) for influenza A and B. Xofluza inhibits polymerase"/>
 <result pre="FDA approved Baloxavir marboxil (Xofluza) for influenza A and B." exact="Xofluza" post="inhibits polymerase acidic endonuclease, an enzyme essential for viral"/>
 <result pre="used extensively, WHO has recommends the orally administrated tenofovir or" exact="entecavir" post="for the treatment of CHB due to their minimal"/>
 <result pre="due to their minimal drug resistance and side effects [209]." exact="Entecavir" post="is an off-patent drug. The two tenofovir blockbusters for"/>
 <result pre="They are the antidiabetic insulin sensitizer Rosiglitazone, the leukotriene inhibitor" exact="zafirlukast" post="for asthma, antihistamines, and decongestants TRIAC targeting thyroid hormone"/>
 <result pre="for asthma, antihistamines, and decongestants TRIAC targeting thyroid hormone receptor," exact="glutathione" post="transferase inhibitor sulfasalazine for inflammation, and pain and vital"/>
 <result pre="and decongestants TRIAC targeting thyroid hormone receptor, glutathione transferase inhibitor" exact="sulfasalazine" post="for inflammation, and pain and vital dye Chicago Sky"/>
 <result pre="of drug prevention or therapy [214]. During the SARS outbreak," exact="ribavirin" post="was most frequently used to inhibit viral RNA synthesis"/>
 <result pre="was most frequently used to inhibit viral RNA synthesis [74]." exact="Ribavirin" post="is a guanosine analog that inhibits guanosine-triphosphate (GTP) synthesis,"/>
 <result pre="capping, and viral RNA-dependent RNA polymerase [49,20]. At the time," exact="ribavirin" post="was used for Hepatitis C virus (HCV) therapy [233]"/>
 <result pre="respiratory syncytial viral (RSV) infection [42]. The reported uses of" exact="ribavirin" post="in SARS cases showed conflicting results with numerous methodological"/>
 <result pre="distinguished from other treatments such as corticosteroids or other antivirals." exact="Ribavirin" post="treatment for SARS was not tested in clinical trials,"/>
 <result pre="the reliability and sensitivityJ. Virol. Methods1732201135335621419168 74GraciJ.D.CameronC.E.Mechanisms of action of" exact="ribavirin" post="against distinct virusesRev. Med. Virol.1612006374816287208 75GrimmD.ThimmeR.BlumH.E.HBV life cycle and"/>
 <result pre="immunity against multiple influenza serotypesEur. J. Immunol.37920072441244917668898 191TapiaG.HÃ¸jenJ.F.Ã–kvistM.OlesenR.LethS.NissenS.K.Sequential vacc-4x and" exact="romidepsin" post="during combination antiretroviral therapy (cART): immune responses to vacc-4x"/>
 <result pre="on p24 and changes in HIV reservoirsJ. Infect.756201755557128917661 192TassopoulosN.C.VolpesR.PastoreG.HeathcoteJ.ButiM.GoldinR.D.Efficacy of" exact="lamivudine" post="in patients with hepatitis B e antigen-negative/hepatitis B virus"/>
 <result pre="e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B." exact="lamivudine" post="precore mutant study groupHepatology293199988989610051494 193TayM.Z.PohC.M.ReniaL.MacAryP.A.NgL.F.P.The trinity of COVID-19: immunity,"/>
 <result pre="A.8921199210537105411438243 212WinckelmannA.MorcillaV.ShaoW.SchleimannM.H.HojenJ.F.SchlubT.E.Genetic characterization of the HIV-1 reservoir after Vacc-4x and" exact="romidepsin" post="therapy in HIV-1-infected individualsAids321320181793180229762162 213WongJ.H.LegowskaA.RolkaK.NgT.B.HuiM.ChoC.H.Effects of cathelicidin and its"/>
 <result pre="as potent inhibitors of SARS-associated coronavirusAntivir. Ther.103200539340315918330 233ZhouS.LiuR.BaroudyB.M.MalcolmB.A.ReyesG.R.The effect of" exact="ribavirin" post="and IMPDH inhibitors on hepatitis C virus subgenomic replicon"/>
</results>
